François, Eric <br/><br/>
Efficacy and Safety of Bevacizumab Combined With First-Line Chemotherapy in Elderly (≥75 Years) Patients With Metastatic Colorectal Cancer: A Real-World Study.  [electronic resource] 

 -  Clinical colorectal cancer  09 2020 
 - e100-e109 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1938-0674 
<br/><br/><label>Standard No.: </label>10.1016/j.clcc.2020.02.009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Age Factors<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Bevacizumab--administration & dosage<br/>Colorectal Neoplasms--drug therapy<br/>Female<br/>France--epidemiology<br/>Geriatric Assessment--statistics & numerical data<br/>Hemorrhagic Stroke--chemically induced<br/>Humans<br/>Male<br/>Mesenteric Ischemia--chemically induced<br/>Progression-Free Survival<br/>Prospective Studies